Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 6, 2016, Pages 783-794

  Athalye Jape, Gayatri ^a,b,c   Rao, Shripada ^a,b,c   Patole, Sanjay ^a,c  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

enteral nutrition; life cycle; neonates; nutrition, probiotics; research and diseases

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; CINAHL; COCHRANE LIBRARY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); DATA SYNTHESIS; EMBASE; HOSPITALIZATION; HUMAN; LACTOBACILLUS REUTERI; LACTOBACILLUS REUTERI DSM 17938; MEDLINE; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STATISTICAL ANALYSIS; SUPPLEMENTATION; SYSTEMATIC REVIEW; ENTERIC FEEDING; GASTROINTESTINAL MOTILITY; GESTATIONAL AGE; INFANT NUTRITION; LOW BIRTH WEIGHT; NEWBORN; TREATMENT OUTCOME;

ENTERAL NUTRITION; ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL MOTILITY; GESTATIONAL AGE; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LACTOBACILLUS REUTERI; PROBIOTICS; TREATMENT OUTCOME;

EID: 84978976670     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115588113     Document Type: Article

References (42)

1. Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK,. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics. 2006; 117 (4): 1253-1261.
2. Fewtrell MS, Cole TJ, Bishop NJ, Lucas A,. Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease? J Pediatr. 2000; 137 (5): 668-673.
3. Singhal A, Cole TJ, Lucas A,. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet. 2001; 357 (9254): 413-419.
4. Singhal A, Fewtrell M, Cole TJ, Lucas A,. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 2003; 361 (9363): 1089-1097.
5. Franz AR, Pohlandt F, Bode H, Mihatsch WA, Sander S, Kron M,. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support. Pediatrics. 2009; 123 (1): e101-e109.
6. Vohr BR, Allan W, Katz KH, Schneider KC, Ment LR,. Early predictors of hypertension in prematurely born adolescents. Acta Paediatr. 2010; 99 (12): 1812-1818.
7. Clark RH, Wagner CL, Merritt RJ, Bloom BT, Neu J, Young TE,. Nutrition in the neonatal intensive care unit: how do we reduce the incidence of extrauterine growth restriction? J Perinatol. 2003; 23 (4): 337-344.
8. AlFaleh K, Anabrees J,. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014; 10 (4): CD005496.
9. Tarnow-Mordi W, Soll RF,. Probiotic supplementation in preterm infants: it is time to change practice. J Pediatr. 2014; 164 (5): 959-960.
10. Barrington KJ,. Review: probiotics prevented necrotising enterocolitis and reduced mortality in preterm neonates. Arch Dis Child Educ Pract Ed. 2011; 96 (5): 199.
11. Downard CD, Renaud E, St Peter SD, et al.2012 American Pediatric Surgical Association Outcomes Clinical Trials Committee. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2012; 47 (11): 2111-2122.
12. Janvier A, Malo J, Barrington KJ,. Cohort study of probiotics in a North American neonatal intensive care unit. J. Pediatr. 2014; 164 (5): 980-985.
13. Luoto R, Ruuskanen O, Waris M, Kalliomäki M, Salminen S, Isolauri E,. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2014; 133 (2): 405-413.
14. Manzoni P, Rizzollo S, Vain N, et al. Probiotics use in preterm neonates: what further evidence is needed? Early Hum Dev. 2011; 87 (suppl 1): S3-S4.
15. Hunter C, Dimaguila MA, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ,. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis. BMC Pediatr. 2012; 12: 142.
16. Athalye-Jape G, Deshpande G, Rao S, Patole S,. Benefits of probiotics on enteral nutrition in preterm neonates: a systematic review. Am J Clin Nutr. 2014; 100 (6): 1508.
17. Caplan MS, Sun XM, Hseuh W, Hageman JR,. Role of platelet activating factor and tumor necrosis factor-α in neonatal necrotizing enterocolitis. J Pediatr. 1990; 116: 960-964.
18. Liu Y, Zhu L, Fatheree NY, et al. Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G442-G450.
19. Coggins SA, Wynn JL, Weitkamp J-H,. Infectious causes of necrotizing enterocolitis. Clin Perinatol. 2015; 42 (1): 133-154.
20. Liu Y, Tran DQ, Fatheree NY, Marc Rhoads J,. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2014; 307 (2): G177-G186.
21. Savino F, Fornasero S, Ceratto S, et al. Probiotics and gut health in infants: a preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938. [published online 19, 2015 ]. Clin Chim Acta.
22. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Francavilla R,. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr. 2008; 152 (6): 801-806.
23. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R,. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. Physiol Pharmacol. 2009; 60 (suppl 6): 27-31.
24. Liu Y, Fatheree NY, Mangalat N, Rhoads JM,. Human derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2010; 299 (5): G1087-G1096.
25. Liu Y, Fatheree NY, Mangalat N, Rhoads JM,. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-B signaling in the intestine. Am J Physiol Gastrointest Liver Physiol. 2012; 302 (6): G608-G617.
26. Centre for Reviews and Dissemination. CRD's guidance for undertaking reviews in health care. www.york.ac.uk/inst/crd/systematic-reviews-book.htm. Accessed November 28, 2014.
27. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
28. Deshpande G, Rao S, Patole S, Bulsara M,. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010; 125 (5): 921-930.
29. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Cambridge, UK: The Cochrane Collaboration; 2011.
30. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25 (9): 603-605.
31. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J,. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343: d4002.
32. Coleta E, Gheonea M, Sarbu M,. Oral supplementation with probiotics in premature infants: a randomised clinical trial. Intensive Care Med Conf. 2013; 39 (Suppl 1): S1-S200.
33. Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F,. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol. 2011; 31 (1): 63-69.
34. Oncel MY, Arayici S, Sari FN, et al. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. [published online 9, 2014 ]. J Matern Fetal Neonatal Med.
35. Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N,. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2014; 99 (2): F110-F115.
36. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA,. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012; 130 (5): e1113-e1120.
37. Gal P, Dimaguila MAVT, Wilson T, Wimmer JE,. Effect of routine Lactobacillus reuteri DSM 17938 use on rates of late-onset infection in extremely low birth weight infants. J Prob Health. 2013; 1 (2): 105.
38. Mangalat N, Liu Y, Fatheree NY, et al. Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial. PLoS One. 2012; 7 (9): e43910.
39. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M,. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013; 132 (6): 1055-1062.
40. Urba.,ska M, Szajewska H,. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. 2014; 173 (10): 1327-1337.
41. Connolly E,. State of the art on research of Lactobacillus reuteri. Minerva Pediatr. 2009; 61 (6): 634-636.
42. Deshpande GC, Rao SC, Keil AD, Patole SK,. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med. 2011; 9: 92.